A retrospective case-control study comparing 2 opioid risk mitigation tools in noncritical, nonsurgical hospitalized patients

20250 citationsJournal Article

Authors

The results imply PRODIGY is more sensitive than MOSS in identifying noncritical, nonsurgical hospitalized patients at risk for OIRD.

Published in: American Journal of Health-System Pharmacy

Field-Weighted Citation Impact: 0.00